Current status and the perspective of treatment strategy for the patients with advanced or recurrent breast cancer
Kitagawa, D.; Toi, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 65 Suppl. 6: 396-401
2007
ISSN/ISBN: 0047-1852 PMID: 17682183 Document Number: 607036
Document emailed within 1 workday
Related Documents
Kawamura, M.; Nakano, S.; Kyoda, S.; Tabei, I.; Yoshida, K.; Takeyama, H. 2013: Administration of low-dose albumin-bound paclitaxel for the treatment of advanced and recurrent breast cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(7): 909-912Horinouchi, H. 2018: II. Treatment Strategy for Locally Advanced Non-Small Cell Lung Cancer - Perspective of Medical Oncologist Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(8): 1152-1154
Taguchi, T.; Koyama, H.; Yayoi, K.; Wada, T.; Takatsuka, Y.; Sonoo, H.; Morimoto, K.; Tominaga, T.; Abe, R.; Enomoto, K. 1995: Long-term clinical study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 495-508
Matter, M.; Dusmet, M.; Chevalley, F. 2000: The place of surgery in the treatment of advanced localized, recurrent and metastatic breast cancer Revue Medicale de la Suisse Romande 120(6): 485-490
Adami, H.O.; Aspegren, K.; Graffman, S.; Holmberg, L. 1987: Breast-sparing surgery in the treatment of breast cancer--report of the current status Lakartidningen 84(15): 1262-1265
Taguchi, T.; Mori, S.; Abe, R.; Hasegawa, K.; Morishita, Y.; Tabei, T.; Sasaki, Y.; Fujita, M.; Enomoto, K.; Hamano, K. 1994: Late phase Ii clinical study of RP56976 (docetaxel) in patients with advanced/recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(15): 2625-2632
Small, W.; Lurie, R.H. 2001: Current status of radiation in the treatment of breast cancer Oncology 15(4): 469-76; Discussion 476 479-80 482-4 Passim
Wang, L.-p.; Shen, K.-w.; Shan, Z.-z. 2005: Advance and current status of exemestane and androstadienes in the treatment of breast cancer Zhonghua Zhong Liu Za Zhi 27(12): 764-766
Angelescu, N.; Popa, E.; Bordea, A.; Jitea, N.; Burcoş, T.; Florea, I.; Aldea, C.; Zodieru, I. 2002: The therapeutical strategy for locally advanced breast cancer Chirurgia 97(4): 357-363
Yamaguchi, S.; Komoriyama, H.; Tsukikawa, S.; Imaki, S.; Morikubo, M.; Asakura, T.; Okamura, R.; Fukuda, M.; Kanasugi, K.; Watanabe, H. 1990: UFT-MT therapy in advanced or recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(12): 2437-2441
Tokuda, Y. 2014: The Japanese Breast Cancer Society Breast Cancer Registry in the National Clinical Database: current status and future perspectives Nihon Geka Gakkai zasshi 115(1): 17-21
Makino, H.; Iraha, M.; Manba, N.; Hashidate, H.; Shiotani, M. 2012: Utility of serum human epidermal growth factor receptor-2 extracellular domain(HER2 ECD)assessment in patients with advanced or recurrent breast cancer and those who received neoadjuvant therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(2): 237-240
Wada, Y.; Otoshi, M.; Jitsuko, A.; Nishikawa, H.; Takahara, S.; Tsubono, M.; Imai, S. 2007: A phase Ii study of weekly paclitaxel for advanced or recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(7): 1041-1045
Tominaga, T.; Nomura, Y.; Adachi, I.; Aoyama, H.; Nagao, K.; Mitsuyama, S.; Nakamura, Y.; Ogita, M.; Sano, M.; Takashima, S. 1994: Late phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(6): 809-816
Viladiu, P.; Bosch, F.X.; Benito, E.; Alonso, M.C. 1977: Antiestrogen tamoxifen in the treatment of advanced breast cancer: a series of 31 patients Cancer Treatment Reports 61(5): 899-900
Hortobagyi, G.N.; Piccart-Gebhart, M.J. 1996: Current management of advanced breast cancer Seminars in Oncology 23(5 Suppl. 11): 1-5
Abe, O.; Izuo, M.; Enomoto, K.; Kubo, K.; Koyama, H.; Sakai, K.; Terasawa, T.; Tominaga, T.; Nomura, Y. 1982: Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(5): 866-873
Shimizu, S.; Katayama, K.; Matsukawa, H.; Gotoh, H.; Matsumoto, A.; Yokoyama, H.; Suda, T.; Gotoh, H.; Arita, M.; Jojima, T. 1986: Clinical evaluation of adriamycin ointment in advanced or local recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(3 Part 1): 590-592
Miglietta, L.; Vanella, P.; Canobbio, L.; Parodi, M.A.; Guglielmini, P.; Boccardo, F. 2009: Clinical and pathological response to primary chemotherapy in patients with locally advanced breast cancer grouped according to hormonal receptors, Her2 status, grading and Ki-67 proliferation index Anticancer Research 29(5): 1621-1625
Toita, T.; Ariga, T.; Kasuya, G.; Hashimoto, S.; Maemoto, H.; Heianna, J.; Kakinohana, Y.; Murayama, S. 2015: Current Status and Perspective of Chemoradiotherapy for Uterine Cervical Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(10): 1156-1161